TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Genscript Biotech ( (HK:1548) ) is now available.
Genscript Biotech Corporation has announced a board meeting scheduled for August 16, 2025, to review and approve the interim results for the first half of the year ending June 30, 2025. The meeting will also consider the possibility of declaring an interim dividend, which could have implications for the company’s financial strategy and shareholder returns.
More about Genscript Biotech
Genscript Biotech Corporation is a company incorporated in the Cayman Islands, operating in the biotech industry. It focuses on providing innovative products and services, although specific details about its market focus or primary offerings are not provided in the announcement.
YTD Price Performance: 68.70%
Average Trading Volume: 29,093,826
Technical Sentiment Signal: Buy
Current Market Cap: HK$36.01B
Find detailed analytics on 1548 stock on TipRanks’ Stock Analysis page.